1 BACKGROUND: Ramularia collo-cygni (Rcc) is responsible for Ramularia leaf 2 spot (RLS), a foliar disease of barley contributing to serious economic losses. 3 Protection against the disease has been almost exclusively based on fungicide 4 applications, including Succinate Dehydrogenase Inhibitors (SDHIs). In 2015 5
Introduction 21
Ramularia collo-cygni (Rcc) is the causal agent of Ramularia leaf spot 22 (RLS), a major barley disease in the UK. 1 It can cause yield losses of up to 1 t 23 ha -1 , corresponding to around 18% of average yield in the UK. 2 Although there 24 is an increasing interest in breeding for host resistance, there currently are no 1 lines of barley fully resistant to RLS, although varieties differ in their level of 2 susceptibility to the pathogen. 1,3-6 Therefore protection against RLS remains 3 based on foliar fungicide applications. Ramularia collo-cygni has already 4 developed resistance to Quinone outside Inhibitors (QoIs), a fungicide class 5 which initially provided good control of the disease. 7-9 Currently RLS is 6 controlled by a wide range of fungicides comprising Succinate Dehydrogenase 7 Inhibitors (SDHIs), Demethylation Inhibitors (DMIs) and a multisite inhibitor 8 chlorothalonil. 1 Declines in field efficacy to both SDHIs and DMIs have been 9 detected for several plant pathogens. [10] [11] [12] [13] Equally concerning are new 10 directives introduced by the European Commission on pesticide registration 11 (Regulation (EC) No 1107/2009). These directives may restrict future use of 12 some of the DMIs and chlorothalonil 14 , leading to increasing concern about the 13 provision of effective plant protection in the near future. 14 SDHIs are rapidly becoming one of the most important fungicide groups 15 for plant protection with resistance to other fungicide classes reported in many 16 crop pathogens. 15 They were initially introduced in 1966 as two active 17 ingredients carboxin and oxycarboxin that showed a good spectrum of activity 18 against a range of basidiomycete pathogenic fungi. 16 Modern SDHIs are 19 broad-spectrum products, with 19 different active ingredients available, used 20 both as foliar applications and seed treatments (FRAC MOA Poster 2016 21 (www.frac.info)). The current generation of SDHIs was introduced in 2005 for 22 use on cereals in the UK (CRD (https://secure.pesticides.gov.uk/pestreg/)) and 23 are now a mainstay in disease control programmes. In the 2014 growing 24 season 77% of winter barley and 40% of spring barley received SDHI 1 treatment (summing up all reported actives), and the use of some ingredients 2 such as bixafen increased by 94%, fluopyram by 382% and fluxapyroxad by 3 173% as compared to the 2012 growing season (all crops surveyed). 17 The 4 extensive use of SDHIs in plant protection combined with the availability of 5 products containing individual SDHI active ingredients has raised concerns 6 over the evolution of pathogen resistance to SDHIs. Straight SDHI products do 7 not provide anti-resistance strategy 'in the can' and whether cereals growers 8 obey the label guidelines on their proper use, using effective mixing partners 9 at the proper dosage remains uncertain. 10
SDHIs are inhibitors of the mitochondrial respiratory complex II 11 (succinate dehydrogenase, Sdh, EC 1.3.5.1). The target protein of SDHI 12 fungicides, Sdh, consists of four subunits, labelled A-D and it is responsible for 13 oxidising succinate to fumarate and reducing ubiquinone to ubiquinol in the 14 mitochondrial electron transport chain and citric acid cycle. [18] [19] [20] [21] [22] [23] [24] SDHIs inhibit 15 fungal respiration by blocking the ubiquinone binding site, which is formed by 16 residues of subunits B (SdhB), C (SdhC) and D (SdhD). 19, 22, 23, 25, 26 Sdh subunit 17 A (SdhA) is not involved in forming the ubiquinone binding pocket, and no 18 resistance mutations in this subunit have been described. 15, 19 Single amino 19 acid substitutions in SdhB, SdhC and SdhD have been shown to confer 20 resistance to SDHI fungicides. . Replacement of the highly conserved histidine 21 residue in the third cysteine rich cluster [3Fe-4S] of SdhB has been linked with 22 reduced sensitivity in lab mutants of Zymoseptoria tritici (B: H267Y/L/F/N/Q), 27-23 6 isolates of Alternaria alternata (B: H277Y/R). 33 Field resistance to SDHIs had 1 not been commonly detected in cereal pathogens, with the exception of loss 2 of sensitivity mutants to carboxin seed treatment reported for Ustilago nuda 34 showing strong decrease in sensitivity to SDHIs in bioassays, carrying a point 7 mutation in the SdhC gene C: H142R and C: H149R were detected in 8
Germany. An aAdditional mutation C: N83S, conferring a low resistant 9 resistance factor in vitro, was reported in single isolates originating from 10 Germany, Ireland and Slovenia (FRAC 2015 SDHI Working Group 11 (www.frac.info)). This brings a concern about SDHIs field performance in the 12 coming years and the long-term effective protection against RLS. 13
Given that the first isolates with decreased sensitivity to SDHIs in lab 14 assays have evolved recently in Rcc recently (FRAC 2015 SDHI Working 15 Group (www.frac.info)), it is important to obtain the baseline data to which 16 subsequent testing could can be compared to and investigate to investigate 17 possible consequences that resistant population could have on SDHI's field 18 performance. This study reported reports the current level of sensitivity to 19 SDHI fungicides in Rcc in the UK and explored explores the molecular basis 20 of SDHI resistance in UV-induced mutants. Possible mutations in the target 21
Sdh gene related to the resistance phenotype were examined at the nucleotide 22 and protein level and fitness tests were conducted to see whether resistance 23 mutations conferred any fitness penalty. In total 62 isolates sampled from barley in the UK in 2010 (n =7), 2011 (n 4 =18) and 2012 (n =37) were tested in fungicide inhibition assays. Samples 5 collected in 2010 originated from untreated plots in spring barley fungicide 6 performance trial at Bush Estate, Scotland. Samples in 2011 originated from 7 both untreated and treated plots of spring barley fungicide performance trial at 8
Bush Estate, commercial fields in West Sussex, England and random plots in 9 field trials at Lanark, Scotland. In 2012 samples were collected from a spring 10 barley pathology SDHI Ramularia trial, including both untreated and treated 11 plots. Single spore cultures of Rcc were isolated from leaves using a slight 12 modification of the method described by Frei, 35 excluding leaf incubation prior 13 to conidia isolation and using a fine sterile needle instead of a sterile blade. All 14 of the Rcc isolates were maintained on potato dextrose agar (PDA, Oxoid, 15
Basingstoke, UK) media amended with streptomycin 5 µg ml -1 and/or 16 kanamycin 50 µg ml -1 , in a growth cabinet (Sanyo Incubator, MIR-254, Osaka, 17 Japan), in the dark, at 15°C. 18
Fungal cultures for inhibition assay were cultivated in alkyl ester (AE) 19 broth 27 in 250 ml Erlenmeyer flask containing 150 ml of media. Each flask was 20 inoculated with 150 µl of homogenised mycelium and cultured for 10-12 days 21 in the dark at 16°C with shaking at 120 rpm. Subsequently 5 ml of each culture 22 was homogenised for two minutes at 24000 rpm using an Ultra-Turrax T25 23 basic homogenizer (IKA®-Werke, GmbH&Co.KG, Staufen, Germany) with 24 reusable plastic blades (T25 S18D, IKA®-Werke). The suspension was 25 vortexed for an additional minute and filtered through sterile nylon filters with 1 a pore size of 100 µm (Millipore, Darmstadt, Germany). Five SDHI fungicides: 2 isopyrazam, bixafen, boscalid, fluopyram and carboxin (Sigma-Aldrich, Saint 3 Louis, USA) were used in the assay. Each test was performed in a 96 well 4 plate, with three replicates per isolate. To each well 100 µl of mycelial 5 suspension and 100 µl of media containing fungicide at a range of 6 concentrations were added. The final concentration of fungal fragments in the 7 assay was 2.5x10 3 pieces of mycelium ml -1 . Final concentrations of 8 isopyrazam, bixafen, boscalid and fluopyram for field isolates were 10, 5, 1, 9 0.5, 0.1, 0.05, 0.01, 0 mg litre -1 and for carboxin were 50, 10, 5, 1, 0.5, 0.1, 10 0.05, 0 mg litre -1 . For SDHI-resistant mutants the same range of concentrations 11 plus one additional higher concentration of each fungicide was used. This 12 additional concentration was 50mg litre -1 for isopyrazam, bixafen, boscalid, 13 fluopyram and 100 mg litre -1 for carboxin. All the mycelium and fungicide 14 dilutions were made in AE broth. Fungicide stocks were prepared in DMSO. 15
The final highest concentration of DMSO in wells was equal to 1% v/v when 16 the highest concentration of carboxin was used (50 mg litre -1 ) and 0.2% v/v for 17 the highest concentration of the remaining four SDHI fungicides (10 mg litre -1 ). 18
Plates were incubated in the dark for seven days at 16°C shaking at 120 rpm 19 (Gallenkamp, cooled orbital incubator, Weiss Technik Konigswinter, 20
Germany). OD400 measurements, with 20 flashes per well, were taken at day 21 zero and day seven on a spectrophotometer FLUOstar Omega (BMG Labtech, 22
Offenburg, Germany). Data were analysed using MARS Data Analysis 23 Software (BMG Labtech). EC50 values were calculated from the 4-parameter 1 fit of the standard curve. 2
Resistance factors (RFs) were calculated as: RF = (EC50 value of 3 mutant)/(EC50 of parental isolate). The classification of resistance levels was 4 based on Leroux et al. 13 However it was calibrated separately for each 5 fungicide using the RFs for the least sensitive isolates from the UK field 6 population. Resistance factors <0.5 were considered as hypersensitive. 7
Normal sensitivity for isopyrazam and bixafen was in the range ≥0.5<2, 8 ≥0.5<5.5 for boscalid, ≥0.5<7.5 for fluopyram and ≥0.5<3.0 for carboxin. Weak 9 resistance for isopyrazam and bixafen was classified as ≥2<10, for boscalid 10 ≥5.5<10, for fluopyram ≥7.5<10 and for carboxin ≥3<10. Resistance factors 11 ≥10<100 were considered as moderate resistance and ≥100 as high 12 resistance. 13
Generation of SDHI-resistant UV mutants of Rcc 14
Mutants were developed using fungal mycelium fragments because we 15 failed to reliably generate Rcc spores in vitro. 36 to isolate resistant mutants. To define the minimum inhibitory concentration 23 (MIC), isopyrazam in concentrations ranging between 0.0001 and 20 mg litre -24 1 was added to AE plates. 27 Each plate was then inoculated with 1.5x10 4 1 mycelial fragments and cultivated in a phytotron in the dark at 15°C for 18 2 days. The MIC of isoparazam was the lowest concentration for which growth 3 of wild type isolate was not observed after 18 days. 4
Selection for SDHI resistance was performed in AE agar amended with 5 0.05 mg litre -1 (MIC) and 0.1 mg litre -1 (2x MIC) of isopyrazam. Isolate DK05 6 was cultivated in AE broth at 16°C in the dark whilst shaking at 120 rpm for 7 seven days. The culture was homogenised, filtered and adjusted to a final 8 concentration of 10 5 pieces of mycelium ml -1 . Pieces of mycelium were 9 counted in Improved Neubauer C-Chip Disposable haemocytometers (Digital 10 Bio, Seoul, Korea) under the compound microscope using a 40x objective 11 (Leica, PL Fluotar 40x/0.70). Each isopyrazam amended agar plate was 12 inoculated with 1.5x10 4 of mycelial fragments and exposed to UV energy 13 between 12000 and 23000 µJ cm -2 in an UV Stratalinker 2400 (Stratagen, San 14 Diego, USA) leading to between approximately 20% and 50% survival. 15
Immediately after UV treatment, Petri dishes were sealed with parafilm and 16 transferred to the dark to avoid the activation of DNA repair systems in the 17 treated mycelial fragments. Samples were incubated for at least 18 days in the 18 dark at 15°C and; any colonies growing on agar after this period were collected 19 (between 22-33 days after UV treatment). 20
Characterisation of the Sdh gene 21
Prior to DNA extraction, fungal material was freeze dried overnight and 22 tissue lysed (Tissue Lyser LT, Qiagen, Hilden, Germany). DNA extraction was 23 performed using an Illustra Nucleon PhytoPure Genomic DNA Extraction Kit DNA and SDW up to 50 µl. Thermocycler conditions included an initial 17 denaturation at 95°C for two minutes, followed by 30 cycles of denaturation at 18 95°C for 15 seconds, annealing at 58°C for 30 seconds, extension at 72°C for 19 one minute and a final extension at 72°C for ten minutes. After sequencing, all 20 of the DNA fragments were analysed using Sequence Scanner Software v1.0 21 (Applied Biosystems). 22
Fitness tests on SDHI-resistant UV mutants 1
To verify the stability of mutations, mutants were sub-cultured six times 2 on AE agar, not amended with SDHI fungicide and antibiotics. Plates were 3 incubated in the dark at 15°C for seven to ten days between subculture steps. 4
In addition the stability of mutants retrieved from long term storage in 0.25% 5 v/v PDB was verified. Growth of mutants was verified in vitro on agar plates in 6 the dark at 15°C. Cultures of the parental isolate DK05 and mutants were 7 cultivated on AE agar without antibiotics and fungicides for three to four weeks. 8
From each isolate an 8mm plug was excised and transferred into the center of 9 a fresh AE agar plate. Five replicates for each culture were prepared. The 10 growth of a colony was measured using an electronic digital caliper after two 11 and four weeks, in four directions, excluding the mycelium plug. Rcc inoculum was prepared from two week old AE agar plates, cultured 3 at 15°C in the dark. SDW (0.5-1 ml) was added to the plate and mycelium was 4 scraped from the colony surface and centrifuged for three minutes at 4000 5 rpm. It was washed three times with SDW and finally diluted in 1.5 ml of SDW. 6
Each leaf was inoculated in two places with 10 µl of mycelial suspension as 7 
Statistical analysis 20
Statistical analysis was performed in Minitab v16 (Minitab Inc., State 21
College, USA). One way ANOVA was used to examine differences between 22 the group means in in vitro fungicide sensitivity assay. If significant differences 23 between group means were indicated, Tukey's pairwise comparisons were 24 conducted. Pearson product moment correlation coefficients (r) were used to 1 verify the cross resistance patterns between SDHI fungicides. A correlation of 2 ≤ 0.35 was categorised as weak, 0.36 to 0.67 as moderate, 0.68 to 1.00 as 3 strong, with correlation coefficients ≥ 0.90 described as very strong. 40 4 5 15 3 Results 1
Baseline sensitivity of Rcc populations to SDHIs 2
A fungicide inhibition assay was used to screen 62 UK isolates collected 3 in 2010, 2011 and 2012, for sensitivity to five SDHI fungicides: isopyrazam, 4 bixafen, boscalid, fluopyram and carboxin (Table 1 ). Isopyrazam and bixafen 5 most effectively inhibited Rcc growth, with mean EC50 values of 0.019 mg litre -6 1 and 0.015 mg litre -1 respectively. Boscalid (EC50 = 0.137 mg litre -1 ) and 7 fluopyram (EC50 = 0.151 mg litre -1 ) also showed good control of the pathogen 8 in vitro. Carboxin (EC50 = 1.120 mg litre -1 ) was the least effective fungicide. 9
There were no significant differences between years in sensitivity of Rcc 10 populations (Table 1Table 1) to isopyrazam (P =0.216), bixafen (P =0.216), 11 boscalid (P =0.262), fluopyram (P =0.110) or carboxin (P =0.079). 12
Identification of the target mutations conferring resistance to 13
SDHIs 14
Twenty two Rcc colonies with putative resistance to SDHIs were isolated 15 after UV mutagenesis (Table S 1 Mut8. In the case of Mut7 the wild type histidine (cat) residue at position 142 14 was substituted with arginine (cgt) (C: H142R), while in the case of isolate Mut8 15 it was substituted with glutamine (caa) (C: H142Q). As was the case above, 16
this particular residue of histidine in SdhC at position 142 (C: H142) is highly 17 conserved across the species (Table 2, Figure 1) . 18
Assessment of SDHI resistance associated with mutations 19
Mut7 (C: H142R) was highly resistant to boscalid fungicide (resistance 20 factor (RF) =1114), and moderately resistant to four other SDHI active 21 ingredients, with high RFs for bixafen (RF =55.31), isopyrazam (RF =44.10), 22 carboxin (RF =32.80) and fluopyram (RF =16.77), compared to the parental 23 isolate DK05 (RF =1) and the least sensitive isolate from the UK field 24 population (Table 3) . Mut8 (C: H142Q) similarly showed the same high level 1 of resistance to boscalid (RF =1114) and moderate resistance to carboxin (RF 2 =19.19), bixafen (RF =10.69) and fluopyram (RF =15.91). However we 3 observed no differences in sensitivity to isopyrazam (RF =0.688) as compared 4 to the parental isolate and the least sensitive isolate from the UK field 5 population (Table 3) . 6
In the case of Mut11 (B: N224I) a moderate level of resistance was 7
observed to most of the tested SDHI fungicides (RF =37.28 for boscalid, RF 8 =12.65 for bixafen, RF =21.82 for fluopyram and RF =13.23 for carboxin), with 9 the exception of isopyrazam to which weak resistance was found (RF =6.758). (Table 3) . 15
Mut2, which had no detectable mutations in SdhB, C or D, showed 16 moderate level of resistance to isopyrazam (RF =31.55) and bixafen (RF 17 =24.51). For the remaining three active ingredients no differences in sensitivity 18
were observed compared to the DK05 and the UK field population (boscalid 19 RF =1.532, fluopyram RF =1.177, carboxin RF =2.752), (Table 3) . 20
We observed a very strong cross resistance (r =0.901, P =0.037) only 21 between isopyrazam and bixafen ( Figure S 3) . For the remainder of the 22 fungicides the correlations in sensitivity to different fungicides were not 23 significant (P >0.05). 24
Fitness tests on SDHI-resistant mutants of Rcc 1

Culture characteristics 2
There were no morphological differences between the mutants and DK05 3 when grown on agar plates (data not shown). There was no difference in the 4 AE broth liquid culture growth phenotype of the Mut1, 7, 8 and 11 compared 5 to the wild type isolates. However Mut2 liquid cultures had a much darker 6 colouration than wild type ( Figure S 4) . At this time it is unclear if other 7 uncharacterised mutations are responsible for this aberrant phenotype in 8
Mut2. 9
Stability of mutations 10
Most of the mutations correlating with resistance to SDHIs in Rcc were 11 stable, with the exception of Mut8 (C: H142Q) in which the target mutation was 12 not detected after the subculturing process. In long term storage, we noted a 13 mixture of resistant and wild type alleles during the sequencing. 14
In vitro plate growth assay 15
Significant differences in growth on agar plates between DK05, Mut1, 16
Mut7, Mut8 and Mut11 were indicated at both time points, after 14 days (P 17 <0.001) and 28 days (P <0.001), (Figure 2 ). After 14 days we observed 18 significantly faster growth than for the wild type for Mut7 (C: H142R) and Mut11 19 (B: N224I), (P <0.05); after 28 days faster growth was observed only for Mut11 20 (B: N224I), (P <0.05), (Figure 2 ). The test was performed separately for Mut2 21 because it failed to grow in the first experiment. In the case of Mut2 we 22 detected no significant differences in growth on agar plates compared to the 23 wild type after 14 days (P =0.532) and 28 days (P =0.916), (Figure 3) . symptoms, initial pepper-like spots expanding to small, brown to blackish 10 necrotic lesions, on the untreated leaf segments were observed 11 macroscopically from 25 dpi for all three isolates used in this study (data not 12 shown). This showed that Mut11 and Mut7 could infect the host plant barley, 13
reproduce successfully by generating spores and complete their life cycle, 14 further suggesting that there was no measurable fitness penalty associated 15 with the target mutations conferring resistance to SDHIs. 16
Infection by isolate Mut11 and Mut7 was not affected by foliar isopyrazam 17 application at a concentration of 1 mg litre -1 . Both mutants were able to form 18 an epiphytic hyphal network on the leaf surface and penetrate multiple stomata 19 ( Figure 4d ). Conidiophores developed, resulting in abundant sporulation, both 20 in stomata and on the leaf surface ( Figure 4e ). The progressing infection of 21 both mutants led to red discolouration of the guard and surrounding epidermal 22 cells (Figure 4g ), followed by rapid development of the typical RLS symptoms 23 from 28 dpi by both Mut7 (Figure 4h ) and M11 (Figure 4i) . In contrast the 24 growth of the parental isolate DK05, was clearly inhibited after treatment with 1 isopyrazam (Figure 4f ). Some hyphae attempted to colonise the leaf surface. This study has shown that presents the baseline sensitivity of Rcc 2 populations to SDHIs in the UK presently remain sensitive to SDHIs. This is, 3 which is of high relevance given that in 2015 the first field isolates with 4 decreased sensitivity to SDHIs in lab assays have beenwere reported in some 5
European countries in 2015 (FRAC 2015 SDHI Working Group 6 (www.frac.info)). Furthermore using UV induced mutants we have 7 characterised mutations correlating with resistance to SDHIs in Rcc and 8 assessed some of its their fitness parameters, giving an insight into the 9 possible behaviour of a resistant population. field isolates, as well as in a laboratory mutant of Z. tritici (C: H145R). 28 19
Histidine residue C: H142 was not predicted to be involved directly in 20 ubiquinone binding and reduction in the Z. tritci Sdh protein model. 28,29 21
However, this histidine residue has been shown to ligate with heme b and its 22 polar propionate side chains form an integral part of the ubiquinone binding 23 pocket, explaining the loss of sensitivity to SDHIs in mutants carrying variant 24 22 C: H145R. 28 In the light of this evidence we suggest that histidine C: H142 acts 1 as a ligand for heme b in Rcc, and this explains the reduced sensitivity to 2 inhibitors of mitochondrial respiratory complex II in mutant Rcc isolates 3 carrying variant C: H142R/Q. 4
Mutation of the serine residue found in Mut1 (B: S217L) has so far only 5 been correlated with resistance to SDHIs in a laboratory mutant of Z. tritici (B: 6 S218F) 28 and has not to date been found for any field resistant pathogen. The 7 mutation we detected in Rcc Mut11 (B: N224I) has been reported to confer 8 SDHI resistance in both artificially induced mutants and in naturally occurring 9 fungal isolates. The Z. tritici laboratory mutant carrying the corresponding 10 asparagine mutation (B: N225I) exhibits reduced SDHI sensitivity, 28 while B. 11 cinerea laboratory mutants 44 and field isolates 13, 30 to be responsible for resistant development to SDHIs in lab mutants of Z. tritici 1 (B: H267Y/L/F/N/Q). 27-29 However, given the limited number of mutants 2 generated in this study, it cannot be excluded that such mutations could 3 develop and contribute to SDHIs efficacy loss in the field. 4
In the case of Mut2 we observed no amino acid changes in the target 5
Sdh enzyme which could be linked with the resistance to some of the SDHIs, 6 isopyrazam and bixafen. Although alterations of the target gene are the most 7 common mechanism responsible for sensitivity loss towards SDHIs among 8 plant pathogenic fungi, 15,19 they are only one of the possible known 9 mechanisms conferring resistance to such fungicides. SDHI-resistant isolates 10 of Corynespora cassiicola, 48 A. alternata 49 and B. cinerea 13 have been 11 reported with no sequence mutation of the Sdh subunit genes. For theAt 12 present moment there is no evidence as toof which of these mechanisms could 13 be responsible for the resistance patterns in Mut2 and further work is needed 14 to investigate this phenomenon. However given that Mut2 was only resistant 15
to some of the SDHIs tested, overexpression of the target gene or its multiple 16 copies seem to be the two most likely possibilities. 17
We noted positive cross resistance profiles in this study only between 18 isopyrazam and bixafen; for the remaining SDHI active ingredients tested we 19 observed a lack of cross resistance. Although FRAC classifies inhibitors of 20 mitochondrial respiratory complex II as cross resistant 15 , recent studies have 21 demonstrated a lack of cross resistance between newer SDHIs. 19,28,29,44,50,51 22
In Rcc SDHI-resistant mutants the resistance profiles varied notably between 23 the mutated isolates and were strongly associated with the particular position 24 of amino acids. For example Mut7 (C: H142R) was highly resistant to boscalid 1 but moderately resistant to the other four tested SDHIs. Mut11 (B: N224I) was 2 moderately resistant to all SDHIs tested, with the exception of isopyrazam to 3 which weak resistance was observed. This suggests that different mutations 4 could differently influence the affinity of SDHIs to the target site, explaining the 5 limited positive cross resistance among mutated isolates. Additionally it cannot 6 be ruled out that additional mutations, outside the Sdh gene, incurred occurred 7 as a consequence of UV mutagenesis studies, and have an impact on the 8 sensitivity profiles of Rcc UV mutants. 9
No measurable fitness penalty associated with resistance to SDHIs was 10 observed in terms of radial colony growth on agar plates in any of the mutated 11 isolates. Additionally in planta assays performed for two isolates, Mut7 (C: 12 H142R) and Mut11 (B: N224I), indicated that both of the mutants were able to 13 colonise the leaf and effectively reproduce in untreated barley leaves as well 14
as barley leaves treated with isopyrazam. These results are consistent with 15 previous studies on SDHI-resistant mutants of Z. tritici, which were able to 16 colonise the leaf, cause symptoms and produce spores, despite the impaired 17 enzyme activity due to mutation. 28, 29 Although the concentration of isopyrazam 18 used in this study of 1mg litre -1 may not give a good measure of fitness in the 19 presence of commercial rates of fungicide application, it provides a good 20 estimation of fitness in the presence of rates sufficient to eliminate non-21 resistant genotypes. Thus the extrapolation of this data to field conditions 22 should be taken with caution. More fitness tests on a wider variety of traits, 23 especially on recently emerged reduced sensitivity field isolates of Rcc, should 24
Commented [MP1]: I had to change this section. Assuming that Mut8 might have been picked up as mixed colony our previus discussion in that point was irrelevant and too speculative be performed to fully understand the behaviour of resistant population and their 1 influence on SDHIs field performance. Additionally it will be important to verify 2 if the recorded field mutations reappear in the following seasons, and if yes so, 3 in what frequency. In this study most of the mutations were stable in the 4 absence of fungicide, except Mut8 (C: H142Q). Mut8 was either undergoing 5 the process of reversion to the wild type haplotype at the SdhC gene or was 6 originally picked up as a mixed colony of a wild type and a mutant which could 7 explain differences in its sensitivity profiles as compared to Mut7 (C: H142R). 8
This suggests that mutations responsible for SDHI resistance in Rcc could can 9 be stable, a possibility which needs further verification. to reliance f relying only on molecular screening tests alone. Ramularia collo-20 cygni has been exposed to SDHI fungicides since 2005 in the UK and recent 21 population genetic studies have suggested that it has a high potential for 22 evolutionary adaptation. 9,55,56 Based on the current evidence and the recent 23 
